TENAX THERAPEUTICS, INC. Common Stock Shares Outstanding

Quick Answer

TENAX THERAPEUTICS, INC. reported Common Stock Shares Outstanding of 9.31 million shares for the year ending 2025.

  • TENAX THERAPEUTICS, INC. showed an increase of +172.3% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from TENAX THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2011 to 2025), TENAX THERAPEUTICS, INC.'s Common Stock Shares Outstanding has declined by 60.2%.
  • Historical annual values: Fiscal year 2025: 9.31 million shares | Fiscal year 2024: 3.42 million shares | Fiscal year 2023: 298,281 shares | Fiscal year 2022: 28,648 shares | Fiscal year 2021: 1.26 million shares | Fiscal year 2020: 12.62 million shares | Fiscal year 2019: 6.74 million shares | Fiscal year 2018: 3.79 million shares | Fiscal year 2017: 1.41 million shares | Fiscal year 2016: 1.41 million shares | Fiscal year 2015: 28.12 million shares | Fiscal year 2015: 28.12 million shares | Fiscal year 2014: 27.86 million shares | Fiscal year 2013: 1.93 million shares | Fiscal year 2012: 1.47 million shares | Fiscal year 2011: 23.39 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: